Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Field Trip Health Ltd (FTRP.TO)

Field Trip Health Ltd (FTRP.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 71,342
  • Shares Outstanding, K 58,002
  • Annual Sales, $ 961 K
  • Annual Income, $ -23,118 K
  • 60-Month Beta N/A
  • Price/Sales 18.25
  • Price/Cash Flow N/A
  • Price/Book 0.91
Trade FTRP.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.88
  • Most Recent Earnings -0.26 on N/A
  • Next Earnings Date 06/23/22
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Care

    TSX Bottom 100 Stocks

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate -0.22
  • Number of Estimates 3
  • High Estimate -0.18
  • Low Estimate -0.25
  • Prior Year -0.18
  • Growth Rate Est. (year over year) -22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.93 +24.73%
on 05/10/22
1.84 -36.96%
on 04/19/22
-0.64 (-35.56%)
since 04/18/22
3-Month
0.93 +24.73%
on 05/10/22
2.10 -44.76%
on 03/22/22
-0.77 (-39.90%)
since 02/18/22
52-Week
0.93 +24.73%
on 05/10/22
7.90 -85.32%
on 08/03/21
-4.99 (-81.14%)
since 05/18/21

Most Recent Stories

More News
Field Trip and Nue Life Are Collaborating To Bring Psychedelic Therapy Into the Home

TORONTO, May 12, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a leader in the development and delivery of...

FTRP-WT.TO : 0.0150 (-25.00%)
FTRP : 0.9000 (-8.16%)
FTRP.TO : 1.16 (-5.69%)
Field Trip Health Ltd. to Participate in Upcoming Investor Conferences in May 2022

TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development...

FTRP-WT.TO : 0.0150 (-25.00%)
FTRP : 0.9000 (-8.16%)
FTRP.TO : 1.16 (-5.69%)
Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies

Transaction will create two distinct emerging leaders in the psychedelics industry, one providing personalized care and the other developing next...

FTRP-WT.TO : 0.0150 (-25.00%)
FTRP : 0.9000 (-8.16%)
FTRP.TO : 1.16 (-5.69%)
Field Trip Health Ltd. to Participate in Upcoming Investor Conferences

TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development...

FTRP-WT.TO : 0.0150 (-25.00%)
FTRP : 0.9000 (-8.16%)
FTRP.TO : 1.16 (-5.69%)
Stocks in play: Field Trip Health Ltd.

Today announced that the U.S. Patent and Trademark Office has granted the Company a patent for claims ...

FTRP.TO : 1.16 (-5.69%)
Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104

The Allowed Claims include Composition of FT-104 and Provides Protection until 2040...

FTRP-WT.TO : 0.0150 (-25.00%)
FTRP : 0.9000 (-8.16%)
FTRP.TO : 1.16 (-5.69%)
Stocks in play: Field Trip Health Ltd.

Announced today that management will present at the Maxim Group 2nd Annual Virtual Growth Conference, ...

FTRP.TO : 1.16 (-5.69%)
Psychedelics Could Positively Impact the $2.5 Trillion Mental Health Market

Psychedelics could soon revolutionize the $2.5 trillion mental health market. In fact, according to co-CEO of the ATMA Journey Centers, David Harder, a quoted in a company press release, “The surge...

CYBN : 0.5390 (+11.16%)
CLXPF : 3.0200 (-1.31%)
FTRP.TO : 1.16 (-5.69%)
FTRP : 0.9000 (-8.16%)
MCUR.CN : 0.060 (-20.00%)
MCURF : 0.0575 (+7.68%)
ATAI : 3.89 (-5.58%)
NEON.CN : 0.080 (-5.88%)
NMDBF : 0.0530 (-19.08%)
This Could be Game-Changing News for Millions Struggling with Obesity

The world may be a step closer to successfully treating obesity with psilocybin. That's because psilocybin activates serotonin receptors, or "nature's own appetite suppressant," as noted by Psychology...

NEON.CN : 0.080 (-5.88%)
NMDBF : 0.0530 (-19.08%)
CMPS : 8.18 (-8.81%)
CYBN : 0.5390 (+11.16%)
FTRP.TO : 1.16 (-5.69%)
FTRP : 0.9000 (-8.16%)
MNMD : 0.7076 (-8.10%)
Field Trip Health Ltd. to Participate in Maxim Group 2nd Annual Virtual Growth Conference

TORONTO, March 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development...

FTRP-WT.TO : 0.0150 (-25.00%)
FTRP : 0.9000 (-8.16%)
FTRP.TO : 1.16 (-5.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 1.32
2nd Resistance Point 1.28
1st Resistance Point 1.26
Last Price 1.16
1st Support Level 1.20
2nd Support Level 1.16
3rd Support Level 1.14

See More

52-Week High 7.90
Fibonacci 61.8% 5.24
Fibonacci 50% 4.41
Fibonacci 38.2% 3.59
Last Price 1.16
52-Week Low 0.93

See More

Business Summary

Field Trip Health Ltd is engaged in the development and delivery of psychedelic therapies. Its operating segments include Clinical Operations, Research, and Corporate. With its Field Trip Discovery, the company's research division, leading the development of the next generation of psychedelic molecules...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar